Retatrutide

Chemical compound and experimental weight-loss drug that targets three appetite-related hormones

Retatrutide (LY-3437943) is an experimental drug for obesity developed by the American pharmaceutical company Eli Lilly and Company. It is a triple hormone receptor agonist on the GLP-1, GIP, and glucagon receptors.

Also known as...

LY3437943 and LY-3437943

Wikipedia

Health Science Business

Lilly weight loss drug results

Eli Lilly's experimental drug retatrutide shows record-breaking weight loss in clinical trials.

Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express — May 22, 05:17 AM
New weight-loss drug Retatrutide showing stronger results than current options CBS News — May 21, 23:51 PM
Eli Lilly: Next-gen weight loss drug may be more effective than others UPI — May 21, 19:38 PM
New obesity drug from Lilly delivers major weight loss The Hill — May 21, 19:04 PM
A next-generation drug causes dramatic weight loss. Here’s how much. CTV News — May 21, 18:03 PM
New weight-loss shot appears to outperform other obesity drugs on market The Guardian — May 21, 16:50 PM
A Next-Generation Drug Causes Dramatic Weight Loss, Eli Lilly Says Time — May 21, 16:01 PM
New drug helped patients lose 28% of body weight: Eli Lilly CTV News — May 21, 15:57 PM
Next-gen weight loss drug retatrutide trial brings it one step closer to FDA approval Scientific American — May 21, 15:30 PM
Super Ozempic? New weight-loss drug sees even better results in recent study The Independent — May 21, 14:21 PM
New Weight Loss Drug Retatrutide Delivers Stunning Results NBC News — May 21, 12:04 PM
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says NBC News — May 21, 10:45 AM
EU regulator approves pill form of Novo Nordisk's Wegovy weight loss drug Korea Times — May 22, 13:22 PM
Weight-Loss Drugs Show Surprising Ability to Stall Cancer 🔊 Wall Street Journal — May 22, 10:29 AM · 2min
Experimental drug yields dramatic weight loss Boston Globe — May 21, 20:32 PM
Experimental drug helps patients lose 85 pounds on average, study finds Scripps News — May 21, 18:33 PM
New Eli Lilly weight loss drug has dramatic effects in clinical trial Washington Examiner — May 21, 16:32 PM
New weight-loss shot more powerful than old GLP-1s, Eli Lilly says USA Today — May 21, 13:34 PM
Eli Lilly experimental weight loss shot study Boston Globe — May 21, 13:12 PM
Eli Lilly's next-generation weight loss injection posted record results in obesity trial Quartz — May 21, 12:40 PM